Lamisil
Active ingredient: Terbinafine
Delivery: from 4 days
- Worldwide Delivery4-7 business days
- Quality GuaranteedOnly original products
- Bonus pillsSave up to 80%
- 24/7 SupportOur team of pharmacists is available 24/7 to help you
By blocking fungal cell-membrane production, terbinafine in Lamisil targets dermatophyte fungi that cause athlete’s foot, ringworm, jock itch, and other fungal skin infections. Its action is directed at fungi, not bacteria or viruses.
Product information
The tablet form contains terbinafine hydrochloride and is used when oral treatment is clinically appropriate. The regimen for the chosen strength should be confirmed with a healthcare professional before starting.
Active ingredient and drug class
Lamisil contains terbinafine HCl, an allylamine antifungal. “Allylamine” describes a drug family that interferes with an early stage of fungal sterol production. Sterols help maintain the fungal cell membrane; disrupting their formation weakens the organism and can stop its growth.
Fungal cell-membrane action
Terbinafine inhibits an enzyme called squalene epoxidase. This lowers ergosterol production and causes squalene to accumulate inside fungal cells. The result can be toxic to the fungus while the medicine reaches infected tissue through the bloodstream.
How it affects the body
By blocking fungal cell-membrane production, terbinafine in Lamisil targets dermatophyte fungi that cause athlete’s foot, ringworm, jock itch, and other fungal skin infections. Terbinafine inhibits an enzyme called squalene epoxidase. This lowers ergosterol production and causes squalene to accumulate inside fungal cells. The result can be toxic to the fungus.
Ingredients
Terbinafine is active against many dermatophyte fungi associated with tinea infections. The product is supplied as tablets, so it should be used according to the regimen confirmed with a healthcare professional before starting. The diagnosis determines the appropriate treatment route.
Dosage and administration
The product on this page is oral Lamisil tablets containing terbinafine. Topical terbinafine products use the same active substance on the skin, while oral tablets distribute terbinafine through the body and can reach sites such as the nail unit. These routes are not interchangeable.
The tablets sold on this page are taken by mouth. Topical application instructions apply to terbinafine cream or spray, not to oral Lamisil tablets.
For a topical terbinafine product, the practical sequence is:
- Clean the affected skin gently.
- Dry the area thoroughly, including between the toes.
- Apply the topical antifungal to the affected area and nearby skin when the product directions advise this.
- Wash the hands after application unless the hands are being treated.
- Continue for the full stated course, even if itching improves early.
Do not place topical terbinafine in the eyes, mouth, or vagina. Avoid applying it to severely broken skin unless a clinician has specifically directed this. Extra product does not clear fungus faster and can increase irritation.
Occlusive dressings can increase absorption and irritation. Do not cover a treated area with plastic or a tightly sealed dressing unless a healthcare professional has instructed you to do so.
Oral terbinafine can generally be taken with or without food, although taking it with food may be more comfortable for someone who experiences stomach upset. The FDA prescribing information from 2024 states that food does not produce a clinically meaningful change in terbinafine exposure. Take each dose according to the regimen confirmed before treatment and do not double the next dose after a missed dose.
The tablet pack strength does not determine an individual treatment duration. A healthcare professional confirms the regimen before starting, based on the infection site and the person’s medical history.
When not to use it
- Previous allergy to terbinafine or another ingredient
- Current or previous liver disease
- Pregnancy or breastfeeding
- A child or adolescent who has not been assessed for oral treatment
- Suspected nail fungus without diagnostic confirmation
- Extensive, blistering, infected, or rapidly spreading skin disease
- Current medicines that may interact with terbinafine
- A history of significant taste or smell disturbance after antifungal treatment
Oral terbinafine may interact with medicines processed through liver enzymes, including some antidepressants, beta-blockers, antiarrhythmics, and other drugs.
When this is not for you
Lamisil tablets are not suitable for everyone. NOT for you if: oral terbinafine has not been medically assessed for the diagnosis, liver health, and possible interactions.
Pregnancy and breastfeeding require an individual risk assessment. Terbinafine passes into breast milk, so oral treatment during lactation needs a clinician’s decision.
A rash involving the face, scalp, genitals, or large areas of skin may need a different diagnosis and treatment. Pain, pus, fever, extensive blistering, rapidly worsening swelling, or facial involvement raises the need for prompt medical assessment.
Urgent care is needed for breathing difficulty, throat tightness, facial swelling, faintness, or a severe blistering rash after taking Lamisil.
Possible side effects
The fungal infection itself can cause itching, burning, scaling, cracking, and redness. These symptoms should not automatically be attributed to Lamisil.
Topical skin reactions
Topical terbinafine can cause local redness, dryness, burning, stinging, or irritation. Stop topical use and seek urgent help for facial swelling, breathing difficulty, widespread blistering, or a rapidly spreading rash.
Accidental contact with the eyes requires prompt rinsing with clean water. Accidental swallowing, especially by a child, requires urgent medical advice.
Oral terbinafine adverse effects
Oral terbinafine may cause headache, stomach upset, nausea, diarrhoea, indigestion, or taste disturbance. Taste changes can reduce appetite and may persist after treatment in uncommon cases.
Seek prompt medical attention for:
- Persistent nausea or unexplained loss of appetite
- Dark urine or unusually pale stools
- Yellowing of the skin or whites of the eyes
- Severe tiredness, upper-right abdominal pain, or widespread itching
- Facial swelling, wheezing, or breathing difficulty
- Severe blistering or peeling of the skin
- Unusual bruising, recurrent infections, or marked weakness
Taste or smell changes deserve attention. A person who cannot taste food properly may eat less, lose weight, or fail to notice spoiled food.
The EMA product information identifies hepatotoxicity, severe skin reactions, taste disturbance, and blood-related reactions among the important safety considerations for oral terbinafine [2].
Therapeutic indications
Lamisil tablets may be prescribed for confirmed nail fungal infections and selected persistent dermatophyte infections. Common clinical terms include tinea pedis for athlete’s foot, tinea corporis for ringworm of the body, and tinea cruris for jock itch.
The familiar name “ringworm” can be misleading: ringworm is a fungal infection, not a parasitic worm infection. A circular rash can also result from eczema, psoriasis, contact dermatitis, or another condition, so appearance alone cannot establish the diagnosis.
- Athlete’s foot: often affects the spaces between the toes or the soles, causing scaling, cracking, burning, or itching.
- Ringworm: may produce an expanding scaly border on the trunk, limbs, or face.
- Jock itch: commonly affects the groin and upper inner thighs.
- Onychomycosis: fungal infection of a fingernail or toenail, often causing thickening, discolouration, brittleness, or separation from the nail bed.
Moisture between the toes creates a favourable environment for recurrence. Changing damp socks, drying carefully after bathing, and avoiding shared towels can support treatment success.
Scalp infection, vaginal symptoms, bacterial-looking wounds, widespread rash, or an unexplained eruption needs clinical assessment rather than automatic use of an antifungal tablet.
Comparison
| Treatment approach | Main clinical role | Key limitation |
|---|---|---|
| Topical terbinafine | Localised fungal skin infection | Does not reliably reach established fungus deep inside a nail |
| Oral terbinafine tablets | Selected nail or persistent fungal infections | Requires medical review because systemic adverse effects and interactions are possible |
| Non-antifungal treatment | Conditions that resemble tinea | Will not clear a dermatophyte infection |
Topical treatment limits systemic exposure and can suit a small, clearly diagnosed skin infection. Oral treatment may be chosen when infection involves the nail or has not responded to an appropriate topical course, but it requires a higher level of assessment.
Common mistakes
Several habits can reduce treatment success:
- Using tablets for every rash: eczema and psoriasis can resemble tinea but will not respond to terbinafine.
- Stopping when itching disappears: symptoms may improve before fungal clearance.
- Taking extra tablets: more terbinafine does not produce faster nail growth and may increase toxicity.
- Ignoring moisture: damp socks, sweaty footwear, and wet bathroom floors can support recurrence.
- Sharing towels or nail tools: this can spread fungal material to other people or other body sites.
- Applying topical treatment only to the centre of a ring-shaped rash: nearby infected skin may extend beyond the most obvious area.
- Changing treatment after a few days: early appearance does not reliably show whether the antifungal has completed its work.
- Failing to mention all medicines: interaction risk can be missed when supplements and non-prescription products are left out of the history.
What doctors say
In clinical practice, physicians usually separate two decisions: whether the infection is fungal and whether oral treatment is justified. The second decision is more demanding because tablets expose the whole body to terbinafine.
A doctor would also explain that nail recovery is slow even when the antifungal is working. Patients sometimes stop because the nail still looks damaged, although the new growth at the base is healthy.
Another practical point concerns formulation. Topical treatment can be suitable for a limited skin infection, while oral treatment may be considered for confirmed nail disease. Changing from one route to the other without assessment can delay the correct diagnosis and increase unnecessary exposure.
The European Association for Dermatology and Venereology supports confirmation and appropriate management of dermatophyte infections, with treatment selected according to site and severity [4].
Common questions
Can Lamisil be taken with food or on an empty stomach?
Oral terbinafine can generally be taken with or without food, although taking it with food may be more comfortable for someone who experiences stomach upset. The FDA prescribing information from 2024 states that food does not produce a clinically meaningful change in terbinafine exposure. Take each dose according to the regimen confirmed before treatment and do not double the next dose after a missed dose.
Can Lamisil be used during pregnancy or breastfeeding?
Pregnancy and breastfeeding require an individual decision because oral terbinafine enters systemic circulation and passes into breast milk. The EMA’s 2023 safety information advises weighing maternal benefit against potential risk before exposure during pregnancy or lactation. A healthcare professional should review the infection, available alternatives, and breastfeeding plans before oral treatment begins.
What should be done if the expected result does not appear?
A skin infection that does not improve, worsens, or returns needs reassessment rather than an automatic extra course. WHO guidance from 2023 supports confirming the diagnosis and considering other causes when a presumed fungal infection does not respond. Nail improvement is slow, but persistent pain, swelling, drainage, or no healthy growth at the nail base should prompt clinical review.
What should be discussed with a doctor before starting Lamisil?
Mention liver disease, previous terbinafine reactions, pregnancy or breastfeeding, alcohol intake, and every medicine or supplement being used. MOHAP safety practice requires medication decisions to account for patient history, interactions, and monitoring needs. The FDA’s 2024 prescribing information also supports reviewing these factors before oral terbinafine is started. For suspected onychomycosis, discuss whether the diagnosis has been confirmed and whether liver assessment is appropriate before oral treatment.
Can alcohol be used while taking Lamisil?
Alcohol does not create a simple universal prohibition, but regular or heavy drinking can add concern when oral terbinafine is being used because both alcohol and terbinafine involve liver health. The FDA prescribing information from 2024 identifies liver injury as a serious warning associated with oral terbinafine. Avoid heavy alcohol intake and report dark urine, pale stools, jaundice, persistent nausea, or unusual tiredness promptly.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Onychomycosis and toenail fungus
Toenails grow slowly. Even when the fungus is controlled, damaged nail may remain visible until healthy nail grows from the base. Fingernails generally show change sooner than toenails because their growth rate is faster.
The aim is not simply to make the nail look better for a few days. The affected nail must grow out, and the surrounding skin and footwear environment should not repeatedly reintroduce fungal material.
Lamisil treatment duration and clearance
Skin infections can begin to feel better before fungal clearance is complete. Stopping at the first improvement can leave viable fungus behind and increase the chance of recurrence.
Nail infections follow a different timeline. The visible result depends on healthy nail growing from the nail root, so a clear strip near the base is a more useful progress marker than the old damaged portion at the tip.
Treatment duration varies with the infected site, the extent of disease, the nail involved, and the clinical response. A fixed cure time should not be promised.
If symptoms worsen, fail to improve, or return after treatment, reassessment is more useful than repeatedly starting unsupervised courses. The diagnosis may be wrong, reinfection may be occurring, or another condition may be present.
The WHO describes dermatophyte infections as conditions requiring appropriate diagnosis and antifungal management rather than treatment based solely on rash appearance [3].
The FDA prescribing information describes oral terbinafine’s indications, warnings, interactions, and monitoring considerations in detail [1].
Sources
- U.S. Food and Drug Administration (2024). Lamisil (terbinafine hydrochloride) Tablets — Prescribing Information.
- European Medicines Agency (2023). Terbinafine-containing medicinal products — Product information.
- World Health Organization (2023). WHO Guidelines for the Diagnosis and Management of Skin-Related Neglected Tropical Diseases.
- European Association for Dermatology and Venereology (2022). European guideline for the management of dermatophyte infections.